FullScopeMD
US$ 25.73
glp 1 metabolic syndrome GLP-1 Therapy Part 1: Setting Realistic Weight Loss Expectations – Sarah Hormachea Metabolic Syndrome and Type II
Description
As weight-loss drug popularity soars, more benefits and risks of the drugs are emerging.
Ozempic, the popular brand name for Semaglutide, has been at the center of product liability lawsuits due to its alleged link to gastroparesis and other
After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy a shift that could raise costs for patients.
Screen patients for personal or family history before prescribing GLP-1 RAs. The benefits of GLP-1 RAs on cardiovascular health may outweigh any small increase in absolute risk of thyroid cancer.
